ADVERTISEMENT
search.svg

Pharmacy News

In case you missed it: new study warns against acetaminophen use during pregnancy

A recent study published in Nature Reviews Endocrinology sheds light on the debate about acetaminophen use for pregnant women. After reviewing the medical literature on the topic going back 25 years, the research team is urging caution on the use of this common OTC during pregnancy because of the strong link associated with adverse neurological, urogenital, and reproductive outcomes in children.

New impurities lurking in some heart medications

Over the past few years, blood pressure medications have been recalled due to concerns about N-nitrosodimethylamine (NDMA), a probable carcinogen. But this may not be the only impurity to be worried about in these medications. As drug companies have addressed the NDMA issue, they have also found new potentially dangerous chemicals known as azido impurities.

FDA takes steps to improve quality, safety of sunscreens

FDA is working to improve the quality, safety, and efficacy of sunscreens as part of its implementation of new authorities for certain OTC drugs.

Federal government makes two announcements with major pharmacy implications in 24 hours

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

Tocilizumab in short supply due to pandemic

Some individuals with rheumatoid arthritis (RA) are treated with a monthly infusion of the biologic tocilizumab (Actemra—Genentech). However, the drug is now in short supply because of the surge in COVID-19 cases.

RSS
123